Aggregation and analysis of indication-symptom relationships for drugs approved in the USA

PURPOSE: Drug indications and disease symptoms often confound adverse event reports in real-world datasets, including electronic health records and reports in the FDA Adverse Event Reporting System (FAERS). A thorough, standardized set of indications and symptoms is needed to identify these confound...

Descripción completa

Detalles Bibliográficos
Autores principales: Punyala, Ananth, Lankapalli, Rachana, Hindman, Diane, Racz, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419351/
https://www.ncbi.nlm.nih.gov/pubmed/32495081
http://dx.doi.org/10.1007/s00228-020-02898-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419351/
https://www.ncbi.nlm.nih.gov/pubmed/32495081
http://dx.doi.org/10.1007/s00228-020-02898-w

Ejemplares similares